Jefferies upgraded PeptiDream to Buy from Hold with a price target of 1,600 yen, down from 1,900 yen. The analyst says the company seems likely to book a strong Q3 on the back of milestone and upfront payments from Merck, Astellas and Genentech.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>